irinotecan has been researched along with oleic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kang, T; Lee, BJ; Oh, E; Park, C; Vo, CL | 1 |
| Chung, I; Eh Suk, VR; Misran, M | 1 |
3 other study(ies) available for irinotecan and oleic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
New method and characterization of self-assembled gelatin-oleic nanoparticles using a desolvation method via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction.
Topics: Antineoplastic Agents; Biocompatible Materials; Camptothecin; Carbodiimides; Drug Carriers; Drug Compounding; Gelatin; Irinotecan; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Nanoparticles; Oleic Acid; Particle Size; Spectroscopy, Fourier Transform Infrared; Succinimides; Suspensions; Trinitrobenzenesulfonic Acid | 2015 |
Mixed Oleic Acid-Erucic Acid Liposomes as a Carrier for Anticancer Drugs.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Doxorubicin; Drug Carriers; Drug Screening Assays, Antitumor; Erucic Acids; Humans; Irinotecan; Leucovorin; Liposomes; Methotrexate; Oleic Acid; Particle Size; Surface Properties | 2020 |